|
|||||
|
|

Motion control and electronic systems manufacturer Helios Technologies (NYSE:HLIO) reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 3.4% year on year to $212.5 million. On top of that, next quarter’s revenue guidance ($211.5 million at the midpoint) was surprisingly good and 7.2% above what analysts were expecting. Its non-GAAP profit of $0.59 per share was 17.4% above analysts’ consensus estimates.
Is now the time to buy HLIO? Find out in our full research report (it’s free).
Helios Technologies posted second quarter results that were received positively by the market, with revenue and non-GAAP profitability both surpassing Wall Street’s expectations despite a modest year-over-year sales decline. Management attributed the performance to stronger-than-expected demand in its Hydraulics segment and operational discipline across the business. CEO Sean Bagan highlighted progress on portfolio optimization and cost management, noting, “We continued to reduce debt which is lower by $67 million from the year ago period, improving our net debt to adjusted EBITDA leverage ratio to 2.6x.” The company also benefited from foreign exchange tailwinds and incremental growth in targeted end markets.
Looking forward, Helios’ updated guidance reflects confidence in stabilizing core markets and ongoing product innovation. Management believes recent structural changes—including divesting non-core assets and streamlining engineering resources—will improve overall margins and position the company for sequential growth. CEO Sean Bagan emphasized the focus on organic growth, stating, “New products are being launched at a faster pace, many in white spaces providing incremental sales opportunities while not cannibalizing existing sales.” The leadership team expects these actions, along with a strengthening order backlog, to drive improved performance in the second half of the year.
Management cited targeted portfolio moves, market stabilization in key regions, and new product introductions as the major contributors to the quarter’s results and improved outlook.
Helios’ outlook is supported by a more stable demand environment, a focus on operational execution, and a streamlined portfolio targeting higher-margin growth.
In upcoming quarters, the StockStory team will be watching (1) whether market recoveries in agriculture, health and wellness, and recreational segments translate into sustained sales growth, (2) the impact of portfolio changes—including the Custom Fluidpower divestiture—on consolidated margin improvement, and (3) evidence that Helios’ accelerated new product introductions are generating incremental revenue. Execution on cost discipline and further commercial organization refinements will also be important markers of success.
Helios currently trades at $50.53, up from $36.83 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-27 | |
| Oct-23 | |
| Oct-22 | |
| Oct-21 | |
| Oct-20 | |
| Oct-20 | |
| Oct-16 | |
| Oct-07 | |
| Oct-06 | |
| Oct-02 | |
| Oct-02 | |
| Sep-29 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite